ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,618Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 617

$783K Total Retail Price of All Prescriptions

Rank: 13 out of 617

619 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 619 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 619 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 12,496 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 1,042 624 S3 1 8
LEVOTHYROXINE SODIUM 693 603 2 1
POTASSIUM CHLORIDE 566 404 3 10
OMEPRAZOLE 552 409 4 3
FUROSEMIDE 535 425 5 4
ATENOLOL 510 469 6 17
METFORMIN HCL 462 325 7 9
PRAVASTATIN SODIUM 364 292 8 21
ATORVASTATIN CALCIUM 362 281 9 14
WARFARIN SODIUM 349 334 10 7
SIMVASTATIN 333 279 11 2
HYDROCHLOROTHIAZIDE 296 240 12 13
TRIAMTERENE-HCTZ 293 216 13 47
AMLODIPINE BESYLATE 287 257 14 6
GLYBURIDE 268 214 R 15 84
ENALAPRIL MALEATE 264 211 16 34
SERTRALINE HCL 221 176 17 20
METOPROLOL TARTRATE 208 181 18 11
LISINOPRIL 193 181 19 5
TRAZODONE HCL 178 156 20 51
FAMOTIDINE 169 135 21 54
ZETIA 163 153 22 77
ALENDRONATE SODIUM 154 127 23 25
METOPROLOL SUCCINATE 153 131 24 12
CRESTOR 136 121 25 28
GABAPENTIN 136 92 25 16
CEPHALEXIN 133 96 27 68
CYCLOBENZAPRINE HCL 121 74 R 28 74
CYMBALTA 120 96 29 49
CARVEDILOL 115 108 30 19
LANTUS 112 92 31 39
ADVAIR DISKUS 107 54 32 38
PANTOPRAZOLE SODIUM 100 91 33 37
RANITIDINE HCL 99 43 34 40
CLOPIDOGREL 94 89 35 53
ALLOPURINOL 92 92 36 27
TRAMADOL HCL 91 57 37 15
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 58 38 91
ZOLPIDEM TARTRATE 90 82 38 23
CITALOPRAM HBR 88 70 40 18
TAMSULOSIN HCL 88 76 40 26
FLUTICASONE PROPIONATE 86 60 42 36
PREDNISONE 85 68 43 31
AMITRIPTYLINE HCL 85 53 R 43 56
GEMFIBROZIL 83 72 45 105
PLAVIX 82 77 46 86
CARBIDOPA-LEVODOPA 82 70 46 69
TRICOR 79 49 48 83
POLYETHYLENE GLYCOL 3350 76 27 49 32
ACTOS 75 55 50 85
VESICARE 75 51 50 95
LEVETIRACETAM 74 28 52 166
VERAPAMIL ER 73 55 53 90
LOSARTAN POTASSIUM 72 60 54 22
OXYCODONE-ACETAMINOPHEN 70 24 S2 55 93
LEVEMIR 70 53 55 219
TRIAMTERENE-HYDROCHLOROTHIAZID 68 66 57 122
NAMENDA 67 67 58 35
DIOVAN 65 53 59 41
PROAIR HFA 64 25 60 75
SUCRALFATE 63 46 61 143
RAMIPRIL 62 62 62 67
NIASPAN 61 38 63 103
ZOSTAVAX 60 58 64 99
DONEPEZIL HCL 59 53 65 30
NAPROXEN 59 32 65 101
NEXIUM 58 41 67 43
MELOXICAM 58 37 67 24
INSULIN SYRINGE 56 32 69 148
LIPITOR 56 48 69 118
DICLOFENAC SODIUM 55 53 71 98
MECLIZINE HCL 54 46 72 150
PREMARIN 54 25 R 72 108
SPIRIVA 54 37 72 61
ISOSORBIDE MONONITRATE ER 53 51 75 52
SPIRONOLACTONE 53 37 75 42
VYTORIN 51 33 77 160
FLUOXETINE HCL 51 23 77 73
CELEBREX 50 39 79 63
LEVOFLOXACIN 50 43 79 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.